Stevens First Principles Investment Advisors’s AstraZeneca AZN Stock Holding History

Stevens First Principles Investment Advisors’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	$5K	Hold	63	–	–	﹤0.01%	134
2019 Q1	$5K	Hold	63	–	–	﹤0.01%	134
2018 Q4	$5K	Hold	63	–	–	﹤0.01%	132
2018 Q3	$5K	Hold	63	–	–	﹤0.01%	140
2018 Q2	$4K	Buy	+63	New	+$4.53K	﹤0.01%	138

Other funds holding AZN

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

Stevens First Principles Investment Advisors's AZN Position: Q2 2019 in Review

Stevens First Principles Investment Advisors held its AstraZeneca (AZN) position steady in Q2 2019 at 63 shares worth $5K. The position accounts for ﹤0.01% of the portfolio, ranked #134.

Stevens First Principles Investment Advisors first reported a position in AZN in Q2 2018 and has held it in 5 quarters since. 546 funds tracked by Wall St. Rank hold AZN as of Q2 2019.

Stevens First Principles Investment Advisors held 63 shares of AstraZeneca worth $5K as of Q2 2019.
Stevens First Principles Investment Advisors left its AstraZeneca share count unchanged in Q2 2019.
AstraZeneca made up ﹤0.01% of Stevens First Principles Investment Advisors's portfolio in Q2 2019, its #134 holding.
Stevens First Principles Investment Advisors first reported a position in AstraZeneca in Q2 2018 and has held it in 5 quarters since.
546 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2019.

Based on Stevens First Principles Investment Advisors's 13F filing for Q2 2019, filed 22 Jul 2019.